NEUROCRINE BIOSCIENCES INC Investment Income, Net
NEUROCRINE BIOSCIENCES INC (NBIX) reported Investment Income, Net of $2.93 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-04-30.
Discontinued › Income Statement › Other Income
us-gaap:InvestmentIncomeNet · last filed 2018-04-30
- NEUROCRINE BIOSCIENCES INC investment income, net for the quarter ending 2018-03-31 was $2.93M, a 303.30% increase year-over-year.
- NEUROCRINE BIOSCIENCES INC investment income, net for the quarter ending 2017-12-31 was $2.32M, a 224.44% increase year-over-year.
- NEUROCRINE BIOSCIENCES INC investment income, net for the quarter ending 2017-09-30 was $2.02M, a 186.38% increase year-over-year.
- NEUROCRINE BIOSCIENCES INC investment income, net for the quarter ending 2017-06-30 was $1.17M, a 71.91% increase year-over-year.
- NEUROCRINE BIOSCIENCES INC investment income, net for fiscal 2017 was $6.24M, a 119.80% increase from fiscal 2016.
- NEUROCRINE BIOSCIENCES INC investment income, net for fiscal 2016 was $2.84M, a 47.20% increase from fiscal 2015.
- NEUROCRINE BIOSCIENCES INC investment income, net for fiscal 2015 was $1.93M, a 206.52% increase from fiscal 2014.
- NEUROCRINE BIOSCIENCES INC investment income, net for fiscal 2014 was $629.00K, a 56.47% increase from fiscal 2013.
| Period end | Investment Income, Net 3 month | Investment Income, Net 6 month | Investment Income, Net 9 month | Investment Income, Net 12 month |
|---|---|---|---|---|
| 2018-03-31 | $2.93M 10-Q · filed 2018-04-30 | $5.25M derived: sum of 2 quarters · filed 2018-04-30 | $7.27M derived: sum of 3 quarters · filed 2018-04-30 | $8.44M derived: sum of 4 quarters · filed 2018-04-30 |
| 2017-12-31 | $2.32M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-13 | $4.34M derived: sum of 2 quarters · filed 2018-02-13 | $5.51M derived: sum of 3 quarters · filed 2018-02-13 | $6.24M 10-K · filed 2018-02-13 |
| 2017-09-30 | $2.02M 10-Q · filed 2017-11-01 | $3.19M derived: sum of 2 quarters · filed 2017-11-01 | $3.92M 10-Q · filed 2017-11-01 | $4.63M derived: sum of 4 quarters · filed 2018-04-30 |
| 2017-06-30 | $1.17M 10-Q · filed 2017-08-03 | $1.90M 10-Q · filed 2017-08-03 | $2.61M derived: sum of 3 quarters · filed 2018-04-30 | $3.32M derived: sum of 4 quarters · filed 2018-04-30 |
| 2017-03-31 | $727.00K 10-Q · filed 2018-04-30 | $1.44M derived: sum of 2 quarters · filed 2018-04-30 | $2.15M derived: sum of 3 quarters · filed 2018-04-30 | $2.83M derived: sum of 4 quarters · filed 2018-04-30 |
| 2016-12-31 | $716.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-13 | $1.42M derived: sum of 2 quarters · filed 2018-02-13 | $2.10M derived: sum of 3 quarters · filed 2018-02-13 | $2.84M 10-K · filed 2018-02-13 |
| 2016-09-30 | $705.00K 10-Q · filed 2017-11-01 | $1.39M derived: sum of 2 quarters · filed 2017-11-01 | $2.12M 10-Q · filed 2017-11-01 | $2.71M derived: sum of 4 quarters · filed 2018-02-13 |
| 2016-06-30 | $680.00K 10-Q · filed 2017-08-03 | $1.42M 10-Q · filed 2017-08-03 | $2.00M derived: sum of 3 quarters · filed 2018-02-13 | $2.58M derived: sum of 4 quarters · filed 2018-02-13 |
| 2016-03-31 | $737.00K 10-Q · filed 2017-05-09 | $1.32M derived: sum of 2 quarters · filed 2018-02-13 | $1.90M derived: sum of 3 quarters · filed 2018-02-13 | $2.41M derived: sum of 4 quarters · filed 2018-02-13 |
| 2015-12-31 | $584.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-13 | $1.17M derived: sum of 2 quarters · filed 2018-02-13 | $1.67M derived: sum of 3 quarters · filed 2018-02-13 | $1.93M 10-K · filed 2018-02-13 |
| 2015-09-30 | $581.00K 10-Q · filed 2016-11-02 | $1.09M derived: sum of 2 quarters · filed 2016-11-02 | $1.34M 10-Q · filed 2016-11-02 | $1.54M derived: sum of 4 quarters · filed 2017-02-14 |
| 2015-06-30 | $506.00K 10-Q · filed 2016-08-03 | $763.00K 10-Q · filed 2016-08-03 | $960.00K derived: sum of 3 quarters · filed 2017-02-14 | $1.14M derived: sum of 4 quarters · filed 2017-02-14 |
| 2015-03-31 | $257.00K 10-Q · filed 2016-05-05 | $454.00K derived: sum of 2 quarters · filed 2017-02-14 | $630.00K derived: sum of 3 quarters · filed 2017-02-14 | $797.00K derived: sum of 4 quarters · filed 2017-02-14 |
| 2014-12-31 | $197.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14 | $373.00K derived: sum of 2 quarters · filed 2017-02-14 | $540.00K derived: sum of 3 quarters · filed 2017-02-14 | $629.00K 10-K · filed 2017-02-14 |
| 2014-09-30 | $176.00K 10-Q · filed 2015-10-29 | $343.00K derived: sum of 2 quarters · filed 2015-10-29 | $432.00K 10-Q · filed 2015-10-29 | $517.00K derived: sum of 4 quarters · filed 2016-02-11 |
| 2014-06-30 | $167.00K 10-Q · filed 2015-07-29 | $256.00K 10-Q · filed 2015-07-29 | $341.00K derived: sum of 3 quarters · filed 2016-02-11 | $434.00K derived: sum of 4 quarters · filed 2016-02-11 |
| 2014-03-31 | $89.00K 10-Q · filed 2015-04-30 | $174.00K derived: sum of 2 quarters · filed 2016-02-11 | $267.00K derived: sum of 3 quarters · filed 2016-02-11 | $388.00K derived: sum of 4 quarters · filed 2016-02-11 |
| 2013-12-31 | $85.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-11 | $178.00K derived: sum of 2 quarters · filed 2016-02-11 | $299.00K derived: sum of 3 quarters · filed 2016-02-11 | $402.00K 10-K · filed 2016-02-11 |
| 2013-09-30 | $93.00K 10-Q · filed 2014-11-04 | $214.00K derived: sum of 2 quarters · filed 2014-11-04 | $317.00K 10-Q · filed 2014-11-04 | $447.00K derived: sum of 4 quarters · filed 2015-02-09 |
| 2013-06-30 | $121.00K 10-Q · filed 2014-08-06 | $224.00K 10-Q · filed 2014-08-06 | $354.00K derived: sum of 3 quarters · filed 2015-02-09 | $477.00K derived: sum of 4 quarters · filed 2015-02-09 |
| 2013-03-31 | $103.00K 10-Q · filed 2014-05-01 | $233.00K derived: sum of 2 quarters · filed 2015-02-09 | $356.00K derived: sum of 3 quarters · filed 2015-02-09 | $471.00K derived: sum of 4 quarters · filed 2015-02-09 |
| 2012-12-31 | $130.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-09 | $253.00K derived: sum of 2 quarters · filed 2015-02-09 | $368.00K derived: sum of 3 quarters · filed 2015-02-09 | $489.00K 10-K · filed 2015-02-09 |
| 2012-09-30 | $123.00K 10-Q · filed 2013-10-29 | $238.00K derived: sum of 2 quarters · filed 2013-10-29 | $359.00K 10-Q · filed 2013-10-29 | $436.00K derived: sum of 4 quarters · filed 2014-02-11 |
| 2012-06-30 | $115.00K 10-Q · filed 2013-07-26 | $236.00K 10-Q · filed 2013-07-26 | $313.00K derived: sum of 3 quarters · filed 2014-02-11 | $415.00K derived: sum of 4 quarters · filed 2014-02-11 |
| 2012-03-31 | $121.00K 10-Q · filed 2013-05-02 | $198.00K derived: sum of 2 quarters · filed 2014-02-11 | $300.00K derived: sum of 3 quarters · filed 2014-02-11 | $420.00K derived: sum of 4 quarters · filed 2014-02-11 |
| 2011-12-31 | $77.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-11 | $179.00K derived: sum of 2 quarters · filed 2014-02-11 | $299.00K derived: sum of 3 quarters · filed 2014-02-11 | $418.00K 10-K · filed 2014-02-11 |
| 2011-09-30 | $102.00K 10-Q · filed 2012-10-31 | $222.00K derived: sum of 2 quarters · filed 2012-10-31 | $341.00K 10-Q · filed 2012-10-31 | |
| 2011-06-30 | $120.00K 10-Q · filed 2012-07-31 | $239.00K 10-Q · filed 2012-07-31 | ||
| 2011-03-31 | $119.00K 10-Q · filed 2012-05-02 | |||
| 2010-12-31 | $1.54M 10-K · filed 2013-02-08 | |||
| 2009-12-31 | -$1.45M 10-K · filed 2012-02-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |